Related Experiment Videos

Use of ventricular premature complexes for risk stratification after acute myocardial infarction in the thrombolytic

D J Statters1, M Malik, S Redwood

  • 1Department of Cardiological Sciences, St. George's Hospital Medical School, London, United Kingdom.

Insights

Ventricular premature complexes (VPCs) remain a significant predictor of cardiac events after acute myocardial infarction (AMI). Thrombolysis enhances the predictive accuracy of VPC frequency for mortality risk, requiring adjusted risk stratification.

Area of Science:

  • Cardiology
  • Clinical Electrophysiology
  • Critical Care Medicine

Background:

  • The predictive role of ventricular premature complexes (VPCs) for mortality after acute myocardial infarction (AMI) was established before thrombolytic therapy.
  • Thrombolysis has altered the natural history of AMI, necessitating a reevaluation of established risk factors.

Purpose of the Study:

  • To assess the prognostic significance of VPC frequency in patients after AMI, particularly in the context of early thrombolytic therapy.
  • To compare the predictive accuracy of VPC frequency for adverse cardiac events between patients who received thrombolysis and those who did not.

Main Methods:

  • A cohort of 680 patients post-AMI underwent 24-hour Holter monitoring 6-10 days after infarction in a drug-free state.
  • Patients were followed for 1-8 years to record cardiac death, sudden death, and sustained ventricular tachycardia.
  • VPC frequency was analyzed in relation to these outcomes, with subgroup analysis for patients who received thrombolytic therapy.

Main Results:

  • Mean VPC frequency was significantly higher in patients who experienced cardiac death, sudden death, or arrhythmic events within the first year.
  • VPC frequency remained a significant predictor regardless of thrombolysis status.
  • The positive predictive accuracy of VPC frequency for adverse events was greater in patients who received thrombolysis compared to those who did not.

Conclusions:

  • VPC frequency is a valuable prognostic marker after AMI, even with modern thrombolytic treatment.
  • The predictive power of VPC frequency for adverse cardiac events is enhanced in patients treated with thrombolysis.
  • Optimal risk stratification using VPC frequency requires adjusted thresholds for patients who have undergone thrombolytic therapy.

Related Concept Videos